Background/Aim: A combination therapy of esophageal stent and chemoradiotherapy (CRT) is currently considered risky for severe complications. The aim of this study was to assess the safety and efficacy of a fully covered self-expandable metallic stent (FCSEMS) placement in palliating incurable esophageal cancer before and/or after CRT. Patients and Methods: We retrospectively reviewed clinical outcomes of 64 incurable advanced esophageal cancer patients with FCSEMS placement. Forty-two of 64 patients had FCSEMS placement with RT. Results: The rate of all of stent-related complications tended to be higher in patients who had RT, although no significant difference was observed. The stent-related deaths occurred in one patient due to hemorrhage after FCSEMS placement in the RTnegative group. Conclusion: Palliation of dysphagia or fistulas with FCSEMS in patients with incurable esophageal cancer before and/or after RT is not associated with an increased risk of life-threatening complications.
CITATION STYLE
SASAKI, K., OSAKO, Y., URATA, M., NODA, M., TSURUDA, Y., UCHIKADO, Y., … OHTSUKA, T. (2021). Clinical outcomes of fully covered self-expanding metallic stent placement for palliation of incurable esophageal cancer with or without radiotherapy. Anticancer Research, 41(1), 385–389. https://doi.org/10.21873/anticanres.14787
Mendeley helps you to discover research relevant for your work.